End-of-day quote
Other stock markets
|
||
- USD | - |
|
25/04 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.45Cr 204.54Cr |
---|---|---|---|---|---|
Net income 2022 | -90L -75Cr | Net income 2023 | -50L -42Cr | EV / Sales 2022 | - |
Net cash position 2022 | 4.21Cr 351.2Cr | Net cash position 2023 | 3.72Cr 310.2Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01/06/01 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10/21/10 |
Sharon Perry
LAW | General Counsel | - | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16/17/16 |
Robert Conway
CHM | Chairman | 70 | 03/13/03 |
Linda Grais
BRD | Director/Board Member | 68 | 01/07/01 |
1st Jan change | Capi. | |
---|---|---|
+16.44% | 12TCr | |
+18.94% | 11TCr | |
+19.62% | 2.62TCr | |
-25.37% | 1.9TCr | |
-20.21% | 1.57TCr | |
-20.20% | 1.52TCr | |
-47.37% | 1.47TCr | |
+59.91% | 1.46TCr | |
+4.35% | 1.38TCr |